Endoscopic Dilatation of Crohn’s Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic Era

Background and Aims: To investigate the long-term efficacy of endoscopic dilatation of Crohn’s anastomotic strictures and to identify risk and protective factors associated with the need for repeat dilatation or surgery. Methods: A total of 54 patients who had endoscopic balloon dilatations for anas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Crohn's and colitis 2016-10, Vol.10 (10), p.1172-1178
Hauptverfasser: Ding, Nik Sheng, Yip, Wai Man, Choi, C. H., Saunders, Brian, Thomas-Gibson, Siwan, Arebi, Naila, Humphries, Adam, Hart, Ailsa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Aims: To investigate the long-term efficacy of endoscopic dilatation of Crohn’s anastomotic strictures and to identify risk and protective factors associated with the need for repeat dilatation or surgery. Methods: A total of 54 patients who had endoscopic balloon dilatations for anastomotic Crohn’s strictures between 2004 and 2009, with follow-up until June 2014, were identified from a single tertiary center. The primary end points were repeat dilatation or surgical resection, and the impact of radiology, medical therapy, and endoscopic data on these outcomes was analysed with Cox proportional hazards analysis. Results: A total of 151 dilatations were performed on patients with a median age of 52 years [interquartile range (IQR), 46–62 years]. The median duration from the first to the second dilatation was 6 years (IQR, 5–7 years). The median disease duration was 28 years (IQR, 19–32 years). At endoscopy, disease activity was reported in 50/54 (92%) cases, with a median Rutgeerts grading of i2 (range, i0–i4). A median of two (IQR 1–9) dilatations was required, with a time to repeat dilatation of 23 months (IQR 7.2–56.9). Escalation of medical therapy was adopted in 22/54 patients (41% of the study population). On multivariate analysis, only combination therapy (anti-TNFα and immunomodulator) was significantly associated with the (decreased) need for repeated dilatation [hazard ratio (HR) 0.23; 95% CI, 0.07–0.67; p = 0.01]. Anastomotic resections were performed in 10 (18%) patients, with a Rutgeerts score of i4 at initial endoscopic balloon dilatation being associated with this outcome (HR 4.55; 95% CI 1.08–19.29; p = 0.04) on multivariate analysis. Conclusion: Endoscopic balloon dilatation of Crohn’s anastomotic strictures is safe and effective in the long term. We demonstrate that active disease predicts for future surgery, while escalation of medical therapy may decrease the need for repeat dilatation.
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjw072